1.51
price up icon4.86%   0.07
after-market Dopo l'orario di chiusura: 1.55 0.04 +2.65%
loading
Precedente Chiudi:
$1.44
Aprire:
$1.35
Volume 24 ore:
851.95K
Relative Volume:
3.29
Capitalizzazione di mercato:
$698.73K
Reddito:
-
Utile/perdita netta:
$-8.26M
Rapporto P/E:
-0.0282
EPS:
-53.609
Flusso di cassa netto:
$-12.17M
1 W Prestazione:
-65.42%
1M Prestazione:
-78.52%
6M Prestazione:
-75.19%
1 anno Prestazione:
-98.72%
Intervallo 1D:
Value
$1.21
$1.70
Intervallo di 1 settimana:
Value
$1.21
$11.12
Portata 52W:
Value
$1.21
$130.39

Gri Bio Inc Stock (GRI) Company Profile

Name
Nome
Gri Bio Inc
Name
Telefono
(619) 400-1171
Name
Indirizzo
2223 AVENIDA DE LA PLAYA, LA JOLLA
Name
Dipendente
4
Name
Cinguettio
Name
Prossima data di guadagno
2024-11-12
Name
Ultimi documenti SEC
Name
GRI's Discussions on Twitter

Confronta GRI con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
GRI
Gri Bio Inc
1.51 698.73K 0 -8.26M -12.17M -53.61
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
474.62 125.40B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
573.45 65.79B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
555.11 35.18B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
235.74 32.67B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
238.51 26.46B 3.81B -644.79M -669.77M -6.24

Gri Bio Inc Stock (GRI) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2024-12-09 Iniziato H.C. Wainwright Buy

Gri Bio Inc Borsa (GRI) Ultime notizie

pulisher
Apr 02, 2025

GRI Stock Down on Public Offering Despite Encouraging IPF Study Data - MSN

Apr 02, 2025
pulisher
Apr 02, 2025

Gri Bio Announces Closing Of $5.0 Million Public Offering - MarketScreener

Apr 02, 2025
pulisher
Apr 02, 2025

GRI Bio Announces Closing of $5.0 Million Public Offering - GlobeNewswire

Apr 02, 2025
pulisher
Apr 02, 2025

GRI Bio Raises $5M, Eyes $18.3M Total Potential for Breakthrough Autoimmune Treatment - Stock Titan

Apr 02, 2025
pulisher
Apr 02, 2025

GRI Bio Shares Rebound In After-Hours Trading - Stocks Telegraph

Apr 02, 2025
pulisher
Apr 01, 2025

GRI Bio (GRI) Reports Positive Interim Safety Results for IPF Tr - GuruFocus

Apr 01, 2025
pulisher
Apr 01, 2025

Street can a-GRI on phase IIb safety win in IPF with tazarotene - BioWorld MedTech

Apr 01, 2025
pulisher
Apr 01, 2025

GRI Bio Announces $5 Million Public Offering Amid Market Decline - Nasdaq

Apr 01, 2025
pulisher
Apr 01, 2025

GRI Bio Prices up to $13 Million Equity Offering - MarketScreener

Apr 01, 2025
pulisher
Apr 01, 2025

GRI Bio announces $5 million public offering - Investing.com India

Apr 01, 2025
pulisher
Apr 01, 2025

GRI Bio announces $5 million public offering By Investing.com - Investing.com Australia

Apr 01, 2025
pulisher
Apr 01, 2025

GRI Bio Announces Pricing of $5.0 Million Public Offering - GlobeNewswire

Apr 01, 2025
pulisher
Apr 01, 2025

GRI Bio Secures $5M Funding Deal: Warrants Could Add $13.3M More - Stock Titan

Apr 01, 2025
pulisher
Apr 01, 2025

Why Is Nano Cap GRI Bio Stock Skyrocketing On Tuesday?GRI Bio (NASDAQ:GRI) - Benzinga

Apr 01, 2025
pulisher
Apr 01, 2025

GRI Bio’s IPF drug shows promise in early trial By Investing.com - Investing.com South Africa

Apr 01, 2025
pulisher
Apr 01, 2025

GRI Bio reports interim 2-week safety results from Phase 2a study of GRI-0621 - TipRanks

Apr 01, 2025
pulisher
Apr 01, 2025

GRI Bio’s IPF drug shows promise in early trial - Investing.com

Apr 01, 2025
pulisher
Apr 01, 2025

Gri Bio IncIDMC Recommends Continuation Of Study With No Safety Concerns - MarketScreener

Apr 01, 2025
pulisher
Apr 01, 2025

GRI Bio Reports Encouraging Interim 2-Week Safety Results - GlobeNewswire

Apr 01, 2025
pulisher
Apr 01, 2025

Clinical Trial Breakthrough: GRI-0621 Clears Key Safety Milestone for IPF Treatment - Stock Titan

Apr 01, 2025
pulisher
Mar 31, 2025

GRI Bio secures global patents for NKT cell modulators By Investing.com - Investing.com South Africa

Mar 31, 2025
pulisher
Mar 31, 2025

GRI Bio secures global patents for NKT cell modulators - Investing.com

Mar 31, 2025
pulisher
Mar 31, 2025

GRI Bio announces the granting of two global patents for Europe, Japan - TipRanks

Mar 31, 2025
pulisher
Mar 31, 2025

GRI Bio Bolsters Intellectual Property Portfolio with Granting of Two Global Patents for Europe and Japan - GlobeNewswire

Mar 31, 2025
pulisher
Mar 31, 2025

Global Patent Victory: GRI Bio's Breakthrough NKT Cell Treatment for Autoimmune Disease Gets Dual Approval - Stock Titan

Mar 31, 2025
pulisher
Mar 28, 2025

Vallon Pharmaceuticals stock plunges to 52-week low of $4.95 By Investing.com - Investing.com South Africa

Mar 28, 2025
pulisher
Mar 28, 2025

Vallon Pharmaceuticals stock plunges to 52-week low of $4.95 - Investing.com India

Mar 28, 2025
pulisher
Mar 28, 2025

Pre-market Movers: PSTX, HOOK, MDAI, ALEC... - RTTNews

Mar 28, 2025
pulisher
Mar 20, 2025

GRI Bio (GRI) to Release Quarterly Earnings on Thursday - Defense World

Mar 20, 2025
pulisher
Mar 18, 2025

GRI Bio Participates in a Virtual Investor CEO Connect Segment - GlobeNewswire

Mar 18, 2025
pulisher
Mar 18, 2025

GRI Bio's Breakthrough IPF Drug Shows Promise, Key Data Coming Next Quarter - StockTitan

Mar 18, 2025
pulisher
Mar 17, 2025

GRI Bio expects cash to fund operations into Q2 of 2025 - TipRanks

Mar 17, 2025
pulisher
Mar 17, 2025

12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga

Mar 17, 2025
pulisher
Mar 17, 2025

GRI stock touches 52-week low at $5.12 amid market fluctuations - Investing.com

Mar 17, 2025
pulisher
Mar 17, 2025

GRI Bio, Inc. Anticipates Key Phase 2a Data Readouts for GRI-0621 in 2025 While Securing Cash Runway for Operations - Nasdaq

Mar 17, 2025
pulisher
Mar 17, 2025

GRI Bio Reports Full Year 2024 Financial Results and - GlobeNewswire

Mar 17, 2025
pulisher
Mar 17, 2025

GRI Bio's IPF Treatment Shows Promise: Key Clinical Data Coming in 2025 - StockTitan

Mar 17, 2025
pulisher
Mar 14, 2025

GRI Bio, Inc. SEC 10-K Report - TradingView

Mar 14, 2025
pulisher
Mar 11, 2025

GRI Bio regains compliance with Nasdaq minimum bid rule By Investing.com - Investing.com Australia

Mar 11, 2025
pulisher
Mar 11, 2025

GRI Bio Regains Compliance with Nasdaq’s Minimum Bid Price Rule - GlobeNewswire

Mar 11, 2025
pulisher
Mar 11, 2025

GRI Bio Back In Compliance With Nasdaq Minimum Bid Rule - Nasdaq

Mar 11, 2025
pulisher
Mar 11, 2025

GRI Bio regains compliance with Nasdaq minimum bid rule - Investing.com India

Mar 11, 2025
pulisher
Mar 11, 2025

GRI Bio, Inc. Regains Compliance with Nasdaq Minimum Bid Price Rule - Nasdaq

Mar 11, 2025
pulisher
Mar 11, 2025

2 ETFs That Are Surging While U.S. Stocks Are Slumping - The Globe and Mail

Mar 11, 2025
pulisher
Mar 10, 2025

Meta Stock: The Potential and Pitfalls of Its Reality Labs Bet - The Globe and Mail

Mar 10, 2025
pulisher
Feb 25, 2025

Stock market today: Wah Fu Education Group +219.55%, Jet.AI +46.26% among top gainers in early trading - Business Upturn

Feb 25, 2025
pulisher
Feb 21, 2025

GRI Bio announces 1-for-17 reverse stock split to regain Nasdaq compliance - MSN

Feb 21, 2025
pulisher
Feb 20, 2025

GRI Bio Announces Reverse Stock Split - The Manila Times

Feb 20, 2025
pulisher
Feb 20, 2025

GRI Bio Stock Set to Reverse Split on Monday, February 24th (NASDAQ:GRI) - Defense World

Feb 20, 2025
pulisher
Feb 19, 2025

Can GRI Bio's 17:1 Reverse Split Save Its Nasdaq Listing? Key Details Revealed - StockTitan

Feb 19, 2025
pulisher
Feb 19, 2025

GRI Bio, Inc. Participates in the Virtual Investor “Top 5 for ‘25” On-Demand Conference - GlobeNewswire

Feb 19, 2025

Gri Bio Inc Azioni (GRI) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$60.26
price down icon 10.70%
$69.18
price down icon 5.66%
$17.36
price down icon 8.20%
$31.11
price down icon 2.14%
$88.05
price down icon 4.30%
biotechnology ONC
$238.51
price down icon 9.76%
Capitalizzazione:     |  Volume (24 ore):